Real-time, high-throughput measurements of peptide-MHC-I dissociation using a scintillation proximity assay

被引:54
作者
Harndahl, Mikkel [1 ]
Rasmussen, Michael [1 ]
Roder, Gustav [1 ]
Buus, Soren [1 ]
机构
[1] Univ Copenhagen, Expt Immunol Lab, Fac Hlth Sci, DK-2200 Copenhagen N, Denmark
关键词
MHC-I; Peptide; Stability; Dissociation; Scintillation proximity assay; SURFACE-PLASMON RESONANCE; FLUORESCENCE POLARIZATION; IMMUNOGENIC PEPTIDES; MOLECULES; BINDING; STABILITY; HLA-A-ASTERISK-0201; DEPENDS;
D O I
10.1016/j.jim.2010.10.012
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Efficient presentation of peptide-MHC class I complexes to immune T cells depends upon stable peptide-MHC class I interactions. Theoretically, determining the rate of dissociation of a peptide-MHC class I complexes is straightforward; in practical terms, however, generating the accurate and closely timed data needed to determine the rate of dissociation is not simple. Ideally, one should use a homogenous assay involving an inexhaustible and label-free assay principle. Here, we present a homogenous, high-throughput peptide-MHC class I dissociation assay, which by and large fulfill these ideal requirements. To avoid labeling of the highly variable peptide, we labeled the invariant beta 2m and monitored its dissociation by a scintillation proximity assay, which has no separation steps and allows for real-time quantitative measurement of dissociation. Validating this work-around to create a virtually label-free assay, we showed that rates of peptide-MHC class I dissociation measured in this assay correlated well with rates of dissociation rates measured conventionally with labeled peptides. This assay can be used to measure the stability of any peptide-MHC class I combination, it is reproducible and it is well suited for high-throughput screening. To exemplify this, we screened a panel of 384 high-affinity peptides binding to the MHC class I molecule, HLA-A*02:01, and observed the rates of dissociation that ranged from 0.1 h to 46 h depending on the peptide used. (C) 2010 Elsevier B.V. All rights reserved.
引用
收藏
页码:5 / 12
页数:8
相关论文
共 27 条
[11]   Scintillation proximity assay as a high-throughput method to identify slowly dissociating nonpeptide ligand binding to the GnRH receptor [J].
Heise, Christopher E. ;
Sullivan, Susan K. ;
Crowe, Paul D. .
JOURNAL OF BIOMOLECULAR SCREENING, 2007, 12 (02) :235-239
[12]   PREPARATION OF IODINE-131 LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC ACTIVITY [J].
HUNTER, WM ;
GREENWOOD, FC .
NATURE, 1962, 194 (4827) :495-&
[13]   Secondary anchor substitutions in an HLA-A*0201-restricted T-cell epitope derived from Her-2/neu [J].
Joseph, Matthew A. ;
Mitchell, Megan L. ;
Evanseck, Jeffrey D. ;
Kovacs, Jeffrey R. ;
Jia, Liang ;
Shen, Hongmei ;
Meng, Wilson S. .
MOLECULAR IMMUNOLOGY, 2007, 44 (04) :322-331
[14]   Development of a scintillation proximity assay for human insulin-like growth factor-binding protein 4 compatible with inhibitor high-throughput screening [J].
Khawaja, X. Z. .
ANALYTICAL BIOCHEMISTRY, 2007, 366 (01) :80-86
[15]  
KHILKO SN, 1993, J BIOL CHEM, V268, P15425
[16]   MEASURING INTERACTIONS OF MHC CLASS-I MOLECULES USING SURFACE-PLASMON RESONANCE [J].
KHILKO, SN ;
JELONEK, MT ;
CORR, M ;
BOYD, LF ;
BOTHWELL, ALM ;
MARGULIES, DH .
JOURNAL OF IMMUNOLOGICAL METHODS, 1995, 183 (01) :77-94
[17]   One-Pot, Mix-and-Read Peptide-MHC Tetramers [J].
Leisner, Christian ;
Loeth, Nina ;
Lamberth, Kasper ;
Justesen, Sune ;
Sylvester-Hvid, Christina ;
Schmidt, Esben G. ;
Claesson, Mogens ;
Buus, Soren ;
Stryhn, Anette .
PLOS ONE, 2008, 3 (02)
[18]   A QUANTITATIVE ASSAY TO MEASURE THE INTERACTION BETWEEN IMMUNOGENIC PEPTIDES AND PURIFIED CLASS-I MAJOR HISTOCOMPATIBILITY COMPLEX-MOLECULES [J].
OLSEN, AC ;
PEDERSEN, LO ;
HANSEN, AS ;
NISSEN, MH ;
OLSEN, M ;
HANSEN, PR ;
HOLM, A ;
BUUS, S .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1994, 24 (02) :385-392
[19]   LOCALIZATION OF THE SITES OF IODINATION OF HUMAN BETA2-MICROGLOBULIN - QUATERNARY STRUCTURE IMPLICATIONS FOR HISTOCOMPATIBILITY ANTIGENS [J].
PARKER, KC ;
STROMINGER, JL .
BIOCHEMISTRY, 1983, 22 (05) :1145-1153
[20]  
PARKER KC, 1992, J IMMUNOL, V149, P1896